Tanaka E - Search Results

1

Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma.

Kiyosawa K, Tanaka E, Sodeyama T, Furuta K, Usuda S, Yousuf M, Furuta S. Kiyosawa K, et al. Among authors: tanaka e. Jpn J Cancer Res. 1990 Nov;81(11):1089-91. doi: 10.1111/j.1349-7006.1990.tb02517.x. Jpn J Cancer Res. 1990. PMID: 2176199 Free PMC article.

2

Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C.

Yabu K, Kiyosawa K, Mori H, Matsumoto A, Yoshizawa K, Tanaka E, Furuta S. Yabu K, et al. Among authors: tanaka e. Scand J Gastroenterol. 1994 May;29(5):474-9. doi: 10.3109/00365529409096841. Scand J Gastroenterol. 1994. PMID: 7518613

3

Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.

Urushihara A, Sodeyama T, Matsumoto A, Tanaka E. Urushihara A, et al. Among authors: tanaka e. J Med Virol. 1994 Apr;42(4):348-56. doi: 10.1002/jmv.1890420405. J Med Virol. 1994. PMID: 7519250

4

Natural history of hepatitis C.

Kiyosawa K, Tanaka E, Sodeyama T, Furuta S. Kiyosawa K, et al. Among authors: tanaka e. Intervirology. 1994;37(2):101-7. doi: 10.1159/000150363. Intervirology. 1994. PMID: 7529217 Review.

5

[General remarks of acute hepatitis C].

Kiyosawa K, Tanaka E. Kiyosawa K, et al. Among authors: tanaka e. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):487-93. Nihon Rinsho. 1995. PMID: 7563801 Review. Japanese. No abstract available.

6

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.

Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T. Suzuki T, et al. Among authors: tanaka e. J Med Virol. 1995 Jun;46(2):162-8. doi: 10.1002/jmv.1890460215. J Med Virol. 1995. PMID: 7636506

7

Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up.

Tanaka E, Kiyosawa K, Nakatsuji Y, Inoue Y, Miyamura T, Chiba J, Furuta S. Tanaka E, et al. J Med Virol. 1993 Apr;39(4):318-24. doi: 10.1002/jmv.1890390411. J Med Virol. 1993. PMID: 7684063

8

Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents.

Sodeyama T, Kiyosawa K, Urushihara A, Matsumoto A, Tanaka E, Furuta S, Akahane Y. Sodeyama T, et al. Among authors: tanaka e. Arch Intern Med. 1993 Jul 12;153(13):1565-72. Arch Intern Med. 1993. PMID: 7686741

9

Low prevalence of hepatitis C virus infection in patients with auto-immune hepatitis type 1.

Tanaka E, Kiyosawa K, Seki T, Matsumoto A, Sodeyama T, Furuta S, Kumagai T, Kohara M. Tanaka E, et al. J Gastroenterol Hepatol. 1993 Sep-Oct;8(5):442-7. doi: 10.1111/j.1440-1746.1993.tb01545.x. J Gastroenterol Hepatol. 1993. PMID: 7693009

10

Prevalence of hepatitis C virus with different genotypes determined by a group-specific antibody assay in Japanese patients with chronic liver diseases due to hepatitis C virus infection.

Tanaka E, Kiyosawa K, Matsumoto A, Sodeyama T, Urushihara A, Suzuki T, Kobayashi M, Furuta S. Tanaka E, et al. Jpn J Med Sci Biol. 1994 Feb;47(1):47-57. doi: 10.7883/yoken1952.47.47. Jpn J Med Sci Biol. 1994. PMID: 7967159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,380 results

Search Page

Filters